BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu Y, Zhang J, Zhang X, Zhou H, Liu G, Li Q. Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy. Front Pharmacol 2020;11:198. [PMID: 32210805 DOI: 10.3389/fphar.2020.00198] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang G, Wang Y, Fuchs BC, Guo W, Drum DL, Erstad DJ, Shi B, Deleo AB, Zheng H, Cai L, Zhang L, Tanabe KK, Wang X. Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram. Front Oncol 2022;12:913736. [DOI: 10.3389/fonc.2022.913736] [Reference Citation Analysis]
2 Liang Y, Liang Q, Qiao L, Xiao F. MicroRNAs Modulate Drug Resistance-Related Mechanisms in Hepatocellular Carcinoma. Front Oncol 2020;10:920. [PMID: 32695666 DOI: 10.3389/fonc.2020.00920] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
3 Manna D, Sarkar D. Multifunctional Role of Astrocyte Elevated Gene-1 (AEG-1) in Cancer: Focus on Drug Resistance. Cancers (Basel) 2021;13:1792. [PMID: 33918653 DOI: 10.3390/cancers13081792] [Reference Citation Analysis]
4 Xu Q, Xu H, Chen S, Huang W. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:710207. [PMID: 34409040 DOI: 10.3389/fcell.2021.710207] [Reference Citation Analysis]
5 Guo J, Guo M, Zheng J. Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway. Cancer Manag Res 2021;13:773-85. [PMID: 33536785 DOI: 10.2147/CMAR.S281969] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wu Y, Zhang J, Li Q. Autophagy, an accomplice or antagonist of drug resistance in HCC? Cell Death Dis 2021;12:266. [PMID: 33712559 DOI: 10.1038/s41419-021-03553-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Zhang Y, Zhang R, Zeng L, Wang H, Peng R, Zhang M, Zhang H, Yang Z, Gao L, Wang M, Liu J, Petrenko Y. Identification and Validation of a Potential Stemness-Associated Biomarker in Hepatocellular Carcinoma. Stem Cells International 2022;2022:1-18. [DOI: 10.1155/2022/1534593] [Reference Citation Analysis]
8 Ali ES, Rychkov GY, Barritt GJ. Targeting Ca2+ Signaling in the Initiation, Promotion and Progression of Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E2755. [PMID: 32987945 DOI: 10.3390/cancers12102755] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Jingjing H, Hongna H, Wenfu Z, Jianlin L, Guochu H, Yuanjia L, Songlin C, Yueqiang H. Bie Jia Jian Pill Combined with Bone Mesenchymal Stem Cells Regulates microRNA-140 to Suppress Hepatocellular Carcinoma Stem Cells. Int J Stem Cells 2021;14:275-85. [PMID: 33632990 DOI: 10.15283/ijsc20157] [Reference Citation Analysis]
10 Zheng X, Yu C, Xu M. Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy. Front Oncol 2021;11:678333. [PMID: 34262865 DOI: 10.3389/fonc.2021.678333] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
11 Brun S, Pascussi JM, Gifu EP, Bestion E, Macek-Jilkova Z, Wang G, Bassissi F, Mezouar S, Courcambeck J, Merle P, Decaens T, Pannequin J, Halfon P, Caron de Fromentel C. GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal Cancer. J Cancer 2021;12:5432-8. [PMID: 34405006 DOI: 10.7150/jca.58533] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lee J, Kim J, Cho H, Jo S, Jang Y. JIB-04, a Pan-Inhibitor of Histone Demethylases, Targets Histone-Lysine-Demethylase-Dependent AKT Pathway, Leading to Cell Cycle Arrest and Inhibition of Cancer Stem-Like Cell Properties in Hepatocellular Carcinoma Cells. IJMS 2022;23:7657. [DOI: 10.3390/ijms23147657] [Reference Citation Analysis]
13 Martinez-Ruiz GU, Morales-Sanchez A, Pacheco-Hernandez AF. Roles Played by YY1 in Embryonic, Adult and Cancer Stem Cells. Stem Cell Rev Rep 2021. [PMID: 33728560 DOI: 10.1007/s12015-021-10151-9] [Reference Citation Analysis]
14 Chisari A, Golán I, Campisano S, Gélabert C, Moustakas A, Sancho P, Caja L. Glucose and Amino Acid Metabolic Dependencies Linked to Stemness and Metastasis in Different Aggressive Cancer Types. Front Pharmacol 2021;12:723798. [PMID: 34588983 DOI: 10.3389/fphar.2021.723798] [Reference Citation Analysis]
15 Cetin-Atalay R, Kahraman DC, Nalbat E, Rifaioglu AS, Atakan A, Donmez A, Atas H, Atalay MV, Acar AC, Doğan T. Data Centric Molecular Analysis and Evaluation of Hepatocellular Carcinoma Therapeutics Using Machine Intelligence-Based Tools. J Gastrointest Cancer 2021. [PMID: 34910274 DOI: 10.1007/s12029-021-00768-x] [Reference Citation Analysis]